Identification of Potential Drug Targets Implicated in Parkinson's Disease from Human Genome: Insights of Using Fused Domains in Hypothetical Proteins as Probes by Rathankar, N. et al.
International Scholarly Research Network
ISRN Neurology
Volume 2011, Article ID 265253, 10 pages
doi:10.5402/2011/265253
Research Article
Identiﬁcation of Potential Drug Targets Implicated in
Parkinson’s Disease from Human Genome: Insights of
UsingFusedDomainsinHypotheticalProteinsasProbes
N. Rathankar,1 K. A.Nirmala,2 VarunKhanduja,3 and H.G. Nagendra3
1Department of Bioinformatics, School of Bioengineering, SRM University, Kattankulathur, Tamil Nadu 603 203, India
2Physics Department, Bangalore University, Jnanabharathi Campus, Bangalore 560 056, India
3Department of Biotechnology, Sir M. Visvesvaraya Institute of Technology, Near Hunasamaranahalli, Via Yelahanka,
Bangalore 562 157, India
Correspondence should be addressed to N. Rathankar, rathankar@gmail.com
Received 20 April 2011; Accepted 21 May 2011
Academic Editors: A. Conti, C. Johansson, A. Mamelak, and B. Moreno-L´ opez
Copyright © 2011 N. Rathankar et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
High-throughput genome sequencing has led to data explosion in sequence databanks, with an imbalance of sequence-structure-
function relationships, resulting in a substantial fraction of proteins known as hypothetical proteins. Functions of such proteins
canbeassignedbasedontheanalysisandcharacterizationofthedomainsthattheyaremadeupof.Domainsarebasicevolutionary
units of proteins and most proteins contain multiple domains. A subset of multidomain proteins is fused domains (overlapping
domains), wherein sequence overlaps between two or more domains occur. These fused domains are a result of gene fusion events
and their implication in diseases is well established. Hence, an attempt has been made in this paper to identify the fused domain
containing hypothetical proteins from human genome homologous to parkinsonian targets present in KEGG database. The results
of this research identiﬁed 18 hypothetical proteins, with domains fused with ubiquitin domains and having homology with targets
present in parkinsonian pathway.
1.Introduction
Hypothetical proteins basically are deﬁned as “a protein
coded by a gene with no known function based on its
DNA sequence” [2]. Certain regions in hypothetical proteins
are highly conserved between species in both composition
and sequence. Proteins with such regions are annotated as
conserved hypothetical proteins and range from 13% in
E. coli and 14% in Rickettsia prowazekii to 40% in Pyrococcus
abyssi and 47% in Plasmodium falciparum [3]. The human
genome too has about 20% of them classiﬁed as hypothetical
[4–6].
The function of such proteins can be predicted based
on the arrangement of distinct domains [7] in them since
this arrangement in proteomes reﬂects the fundamental
evolutionary diﬀerences in their genomes [8]. But with
proteins containing more than one domain, the general
function can only be suggested. The diﬃculty one observes
in predicting a protein’s function based on domains alone
would be when there are no clear cut boundaries between
any two domains. Proteins with appreciable overlap in their
domain boundaries are known as fused domain containing
proteins or chimeric proteins. Such proteins are formed by
the process of gene duplication and combination during
evolution. Proteins containing such domains are created
by joining two or more genes, which originally code for
separate proteins [9]. Translation of this fusion gene results
in a single polypeptide with functional properties derived
from each of the original proteins [10]. Analysis of these
fused domains in related genomes reveals the fact that fused
domainproteinsineukaryoticgenomescorrespondtosingle,
full-length proteins in prokaryotic genomes [11].
Proteins with fused domains [12] in a genome are likely
to be involved in metabolic and signaling pathways [13].
A study by Chia and Kolatkar [14] illustrates that domain
fusions can be used to predict protein-protein interactions.2 ISRN Neurology
Figure 1: 17 clusters in fused hypothetical proteins containing 36 domains.
Table 1: Summary of 17 clusters along with their involvement in diseases and major functions. Words in bold indicate neurodegenerative
disorders and the role of ubiquitin domains in these disorders.
Cluster no. No. of domains Function of
domains No. of sequences Disease implication
13 6 Ubiquitin & kinase
motor domain 106 Alzheimer’s, Von Hippel Lindau, juvenile
parkinsonism,spinocerebellarataxia
21 1
NTF2, Ubiquitin,
CoA
dehydrogenase
11 Fatty acid disorders
3 20 Myosin Motor 135 Familial hypertrophic cardiomyopathy, neuromuscular
disorders
4 9 Cyclophilin 3 Immunosuppression, antiviral activity
51 6 vWFA & PH,
Ubiquitin 196 Von Willebrand disease, thrombotic thrombocytopenic
purpura (TTP)
6 6 PH & PTB 70 Cardiovascular diseases
71 0 t R N A s y n t h a s e 1 5 Aminoacyl tRNA synthetase- charcot-Marie-Tooth
disease type 2D, Mobius syndrome, cardiac disorders
81 3 Ubiquitin&P L A T 3 2 Neurological disorders
9 5 RNA binding 1 Myxoid liposarcoma, sars
10 5 SIR 2 3 Neurological disorders
11 5 HMG box 10 Alzheimer’sdisease, heart diseases, diabetes and cancer
12 4 PI3K 2 Cancer, diabetes and respiratory
13 4 Sm & Sm-like 8 Inﬂammatory bowel disease, Salla disease, diabetes
14 3 Methyl-CpG and
PH 3
Cancer, Down syndrome-likeAlzheimer’s,
Wiskott-Aldrich syndrome, B-cell chronic lymphocytic
leukemia
15 3 EVH1 1 Wiskott-Aldrich syndrome
16 3 CGH & Ntn 1
Lysosomal storage disease and progressive
neurodegeneration, Farber’s disease, and Alzheimer’s
Disease
17 3
Nidogen,
thyroglobulin type
1
6 Human gastrointestinal cancer, cancer, acute leukemia,
heart diseasesISRN Neurology 3
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Figure 2: Parkinson’s disease pathway from the KEGG disease database. Proteins encircled with red color are the ones having fused domains
with ubiquitin domains (source: the KEGG disease pathway database).
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Figure 3: Domains in cluster-1.
This method has proven to be eﬀective in predicting
functional links between proteins. Analysis of the structures
of multidomain single-chain peptides in their study revealed
that domain pairs located less than 30 residues apart on
Table 2: A description of genes, domains, and type of inheritance
for Parkinson’s disease (source: Nirit Lev and Melamed [1]).
Gene/locus/
assignment
Domains
present Inheritance Age of onset
a-Synuclein/
SNCA/
PARK1 & 4
Synuclein/
ubiquitin-like
Autosomal
dominant/
susceptibility
Early/late
Parkin/PRKN/
PARK2
Parkin and
ubiquitin
Autosomal
recessive/
possible
susceptibility
Juvenile/early
Ubiquitin
C-terminal
hydrolase/
UCH-L1/PARK5
Peptidase,
ubiquitin
Autosomal
dominant/
susceptibility
Late
DJ-1/DJ-1/
PARK7
GATase/
ubiquitin-like
Autosomal
recessive Early
a chain share a physical interface, and their interactions
are conserved. Apart from its normal functions, these
multidomain-containing proteins are also implicated in
several diseases. The bcr-abl fusion protein is a well-known
example of an oncogenic fusion protein and is considered
to be the primary oncogenic driver of chronic myelogenous
leukemia [15]. A study on 70 positionally cloned human
genesmutatedindiseasesfoundthatasigniﬁcantlyhighpro-
portion of these “disease genes” contained several signaling
domains including the DEATH domain and play active roles
in cell signaling [16, 17].
Structural Classiﬁcation of Proteins (SCOP) [18] sug-
gests that these multidomain proteins can be classiﬁed
based on the fold of a protein that contain two or more
domains belonging to diﬀerent classes. Based on this, SCOP4 ISRN Neurology
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Figure 4: Multiple sequence alignment of the fused domains in 6 unique hypothetical proteins and their target sequences (PARK2 and
ubiquitin sequence).
K-X(2)-[LIVM]-X-[DESAK -X(3)- LIVM]-[PAQ]-X(3)-Q-X-[LIVM]-[LIVMC]-[LIVMFY]-X-G-x(4)-[DE]
Ubiquitin 27 K AK I Q D KEG IP PDQ Q R LIF –A G KQLE D 52
113 K AK I Q D KEG IP PDQ Q R LIF –A G KQLE D 138 gi |5912028
22 K EA I S K RF SQ TD– Q VLI FA G LK D 47 gi |10241759 KLKI
park2 : 27 K EV A K RQG VP ADQ L R VI –A G KELR5 2 V FN
43 K E I A A SV IP SEK Q R LIY Q– G VLQ D 68 gi |57997480 S R H
62 K EE I S K RF S TD– Q VLI FA G LK D 87 gi |12052812 KLKI H
27 K RL S R RL VP EEQ Q LLF R– G QLLE D 52 gi |37589137 VK H
27 K RL S R RL VP EEQ Q LLF R– G QLLE D 52 gi |44662819 VK H
] [
Figure 5: PROSITE signature PS00299 comparison in hypothetical sequences for a ubiquitin domain. Square brackets in the signature []
indicate the presence of either of the residues at that position, whereas the x(3) indicates any three amino acids. The red-colored residue
indicates the strictly conserved residues, blue-colored ones indicates the residues present in the regular expression patterns, and the orange-
colored ones indicate the mutant residues as observed from the mutant database.
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Figure 6: Domains in cluster-2.
1.73 classiﬁes the PDB structures with multidomains into
53 folds, which covers 1277 structures in total. A recent
classiﬁcation of multidomains on this SCOP database by
Wang and Caetano-Anoll´ es [19] broadly classiﬁes them into
ﬁve categories, namely, (i) single-domain proteins, (ii) single
domain in multidomain proteins, (iii) domain repeats, (iv)
domain repeats in multidomains, and (v) domain pairs.
Interestingly it is observed that none of these classiﬁcations
addressed the proteins containing fused/overlapping domain
containing proteins. Hence, an attempt has been made by us
in this paper to classify the multidomain proteins from the
HumanHypotheticalproteindatasetintothreemajorclasses,
namely,
(i) nonrepeating and unique domains,
(ii) repeat and nonoverlapping domains, and
(iii) overlapping/fused domains.
Table 3: Hypothetical proteins homologous to KEGG sequences
with fused domains in Parkinson’s disease pathway.
Sl.
no.
The KEGG
protein ID Gi ID Cluster
no.
No. of
Hypothetical
proteins
Gi ID
1 UB 11024714 1 1 5912028
2 PARK2 4758884 1 5 10241759
12052812
44662819
57997480
37589137
3 UBA1 23510338 2 1 12053109
8 4 7018418
7018436
34304594
63994165
4 PINK1 14165272 5 7 1905906
3510234
5912043
12053281
52545876
57997093
57997188
Further, as a case study, an in-depth analysis has been
carried out to elucidate the roles of multidomain proteins
involved in Parkinson’s disease.ISRN Neurology 5
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Figure 7: Pairwise sequence alignment of the fused domains between the ubiquitin sequence and its homolog hypothetical sequence
(gi:12053109).
Table 4: Conservation of domain fusions in Parkinson’s disease targets and human hypothetical sequences.
KEGG sequence Hypothetical protein’s
Gi IDs
Region of domain fusion with the target Sequence identity in
the fused region (%)
Cd00196 Cd01769 Cd01809 UB PARK2 UB PARK2
UB 5912028 14–82, 14–82, 11–82, 4–72, 98
90–158, 90–158, 87–158, 4–72,
166–234 166–234 163–234 5–72
12052812 50–107 52–107 50–105 4–72, 30
4–72,
5–72
44662819 4–72 4–70 3–70 4–72, 30
4–72,
5–72
37589137 4–72 4–70 3–70 4–72, 30
4–72,
5–72
57997480 21–87 20–87 17–87 4–72, 36
4–72,
5–72
PARK2 5912028 14–82, 14–82, 11–82, 4–72, 30
90–158, 90–58, 87–58, 4–72,
166–234 166–234 163–234 5–72
12052812 50–107 52–107 50–105 4–72, 29
4–72,
5–72
10241759 1–67 1–67 1–65 4–72, 30
4–72,
5–72
2.MaterialsandMethods
Characterizing the protein function in a proteome is a
multistep process involving selection of homologs, building
multiple sequence alignment, extracting relevant domain
information, and then targeting them to the proteome using
machine’s learning algorithms such as Hidden Markov Mod-
els (HMMs), Support Vector Machines (SVMs), consensus
sequences, and so forth, in order to denote their functional
annotation. Hence, multiple sequence alignments from the
CDD[20]databasewereusedastargetstobuildHMMs.This
approach has seen successin classifying human proteins with
novel functions [21] .T h ep r o t o c o lf o l l o w e di sb r i e f e db e l o w .
2.1. Step 1: Extracting the Dataset of Multidomain Proteins.
In order to extract the hypothetical proteins with multido-
mains, domain information from the CDD was used as a
resource, and HMMs were built for all the 2009 domains
present in the CDD using the HMMBUILD module of
HMMER.TheseHMMswereusedastargetstosearchagainst
the hypothetical proteins database using the HMMSEARCH
[22] module. Sequences with e-value less than 0.001 were
only considered as meaningful targets, which resulted in a
total of 1,777 sequences.
2.2. Step 2: Extracting Fused Domains Sequences from Mul-
tidomain Sequences. Of these 1777 protein sequences, 9846 ISRN Neurology
Table 5: Mutational analysis of the hypothetical proteins with ubiquitin domains.
Sl. no. Gi ID Mutational positions Function as predicted by protein mutant database (PMD)
1 5912028 Nil No change
2 37589137 I30V Stability is retained.
G35K Melting temperature at pH 3.0 decreases.
3 44662819 I30V Stability is retained.
G35K Melting temperature at pH 3.0 decreases.
4 57997480 G35S Melting temperature at pH 3.0 decreases.
K48R Increase in morphologic response of cells to canavanine, accumulation of
high-molecular-weight ubiquitin conjugates and proteome substrates is observed.
5 12052812 R42L Ubiquitin adenylate aﬃnity for E1 protein decreases.
G35K Melting temperature at pH 3.0 decreases.
6 10241759 R42L Ubiquitin adenylate aﬃnity for E1 protein decreases.
G35K Melting temperature at pH 3.0 decreases.
Table 6: Conservation of domain fusions in Parkinson’s disease targets and human hypothetical sequences.
KEGG sequence Hypothetical
protein Gi IDs
Region of domain fusion with the target Sequence identity in the
fused region Cd01492 Cd01491 UBA1
UBA1 12053109 13–162 13–162 54–162 52/160 = 32%
were with single domain, and 793 belonged to multidomain
sequences. A parameter known as overlapping ratio (L),
deﬁned by
L =
Overlapping length
length of the larger domain
(1)
was calculated for all the 793 multidomain sequences. Thus,
sequences with L = 0 denotes nonoverlapping multidomain
proteins and that with L > 0 denotes multidomain proteins
with fused domains. A cut-oﬀ value of L = 0.50 was chosen
to extract more probable fused domain sequences from the
multidomain sequence dataset.
Thus, these calculations resulted into a total of 360
sequences with nonoverlapping domains (L = 0) and 433
sequences with overlapping or fused domains (L > 0.5).
Interestingly 20% of the domain fusions is prominent due
to the three domains cd00053, cd00054, and cd00079.
2.3. Step 3: Clustering Domains Based on Overlap Data. Fre-
quencies of the fused domains in the hypothetical proteins
dataset was used as an input for clustering using a clustering
software known as Cytoscape [23]. This yielded a total of 17
clusters (Figure 1), of which the largest cluster had a total of
36 domains resulting from 106 hypothetical sequences.
Thisclustercontainingubiquitin,ubiquitin-like&kinase
motor domain(s) sequences were associated with diseases
such as Alzheimer’s, Von Hippel Lindau, juvenile parkinson-
ism, and spinocerebellar ataxia. In a similar way, domains
in each cluster were analyzed by using their functional
information from the CDD, and a table of these clusters with
their functions are as shown in Table 1.
Table 1 indicates clearly that ubiquitin-like domains are
involvedinneurologicaldisorders.Hence,clusterswithfused
cd01388
cd00192
cd00180
cd00053
cd00821
cd00048
cd01246 cd01247
cd01469
cd01472
cd00198
cd01235
cd01450
cd01481
cd01482
cd01476
Figure 8: Domains in cluster-5.
ubiquitin domains were considered for further analysis, as
they could become potential drug targets for a variety of
neurodegenerative disorders [24]. Based on this criteria,
sequences from the clusters 1, 2, 5, and 8 were selected. To
investigate the role of multidomains in neurodegenerative
diseases, fused ubiquitin domains related to Parkinson’s
disease were considered.
Parkinson’s disease (PD) is a progressive disorder of the
central nervous system aﬀecting approximately one million
people in the United States alone, wherein 50,000 new
cases are reported annually [1]. Clinically, the disease isISRN Neurology 7
Table 7: Conservation of domain fusions in Parkinson’s disease targets and human hypothetical sequences in cluster-5.
KEGG sequence Hypothetical
protein Gi IDs
Region of domain fusion with the target Sequence identity in the
fused region (%) Cd00180 Cd00192 PINK1
PINK1
57997188 14–288 19–273 271–501 17
5912043 58–340 63–337 271–501 8
52545876 147–405 152–388 271–501 18
1905906 53–303 57–299 271–501 19
12053281 173–419 173–415 271–501 11
57997093 199–438 193–433 271–501 19
3510234 28–287 34–284 271–501 13
characterized by a decrease in spontaneous movements, gait
diﬃculty, postural instability, rigidity, and tremor [25].
At the molecular level, the details regarding the genes
that have been suggested to cause hereditary parkinsonism,
andchromosomallociassociatedwithParkinsonisminother
families are as tabulated in Table 2.F r o mTable 2,i ti s
clear that ubiquitin/ubiquitin-like domains play a dominant
role in the onset of Parkinson’s disease. Hence, fused
Ubiquitin domain sequences from clusters 1, 2, 5, and 8 were
considered for a detailed investigation to ascertain their roles
as well.
2.4. Step 4: Arrival of a Target Dataset for Parkinson’s
Disease. In order to characterize these hypothetical proteins
with fused domains, 18 sequences belonging to Parkinson’s
pathway were extracted from the KEGG database [26]
(Figure 2)andwerequeriedagainsttheCDD[20].Four(UB,
UBA1, PARK2, and PARK7) out of eighteen sequences were
observed to have fused ubiquitin domains. These sequences
are highlighted in Figure 2, which is illustrated in the KEGG
Parkinson’s disease pathway.
2.5. Step 5: Extracting Relevant Homologues for Parkinson
Diseased Targets. These four Parkinson’s diseased sequences
(UB, UBA1, PARK2 and PINK1) were searched against the
sequences in four clusters (i.e., clusters numbered 1, 2, 5, and
8).
A cut-oﬀ e-value of 1e − 0 4w a su s e da saﬁ l t e rt oa r r i v e
at relevant hypothetical protein homologues. This search
resulted into a total of 18 hypothetical sequences, which
could be potential drug targets. A table representing the
homologues with the sequences from the KEGG database is
as shown in Table 3.
2.6. Step 6: Sequence Analysis of Hypothetical Proteins
Cluster-1: (Ubiquitin, Ubiquitin-Like & Kinase Motor Do-
main(s)). The ﬁrst is the largest cluster amongst the 17
clusters. This cluster (Figure 3) contained a total of 36
domains resulting from 106 hypothetical sequences. Se-
quences in this cluster were associated with neurodegen-
erative disorders such as Alzheimer’s, juvenile parkinsonism,
and spinocerebellar ataxia. A database search for the four
Parkinson’sdiseasedtargets(UB,PARK2,UBA1,andPINK1)
against the sequences in this cluster resulted in six hypo-
thetical sequences from human genome, of which ﬁve were
related to UB, three related to PARK2, and two homologous
to both UB and PARK2 proteins.
AsillustratedinTable 4,thefusionsbetweenthedomains
cd00196, cd01796, and cd01089 are conserved in all these six
hypothetical sequences and their respective protein targets.
A pairwise comparison of these sequences with their targets
are shown in Figure 4 to reiterate the same at the sequence
level.
Mutational Analysis. Mutational analysis of these proteins
was carried out using the PROSITE [27] signature PS00299
(Figure 5).
This signature of 26 residues, from the 27th position
and to the 52nd position, is the characteristic of ubiquitin
domain. Of the four Parkinson’s disease homologs, PARK2
and the Ubiquitin protein (UB) have this signature. A com-
parison of this motif with the homologs of the parkinsonian
targets was carried out, and the mutants were compared
with the protein mutant database (PMD) [28] to infer the
eﬀects of such mutations. A table depicting the mutants in
theubiquitindomainwiththeiralteredfunctionsisasshown
(Table 5).
Cluster-2. Cluster-2 (Figure 6) had 11 domains spanning
a total 11 hypothetical protein sequences. Majority of the
domains in cluster-2 were ubiquitin, NTF2, and ubiquitin-
like domains. Sequences in this cluster were associated
with fatty acid disorders. A database search for the four
parkinson’sdiseasedtargets(UB,PARK2,UBA1,andPINK1)
against the sequences in this cluster resulted in only one
hypothetical protein fromhuman genome.This hypothetical
protein with domains cd01491 and cd01492 being fused, is
seen to be conserved as observed in UBA1 (Table 6). A pair-
wise comparison of the hypothetical sequence (gi:12053109)
with its parkinsonian homolog (UBA1) is as shown in
Figure 7.
Cluster-5. Cluster-5 had 16 domains spanning over 196
hypothetical protein sequences as depticted in Figure 8.
Majority of the domains were PH, vWFA, and Ubiquitin-
like domains. Sequences in this cluster were associated
with von Willebrand disease, thrombotic thrombocytopenic
purpura (TTP), hemolytic uremic syndrome (HUS), and8 ISRN Neurology
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Figure 9: Multiple-sequence alignment of the fused domains in 7 unique hypothetical proteins and PINK1 sequence.
Table 8: Conservation of domain fusions in Parkinson’s disease targets and human hypothetical sequences.
KEGG sequence Hypothetical
protein Gi IDs
Region of domain fusion with the target Sequence identity in the
fused region (%) Cd01488 Cd01489 Cd01490 UBA1
UBA1
63994165 198–377 198–397 197–512 470–671 53
34304594 1–168 1–169 1–303 470–671 48
7018436 30–192 30–200 30–419 470–671 31
7018418 71–368 71–331 71–342 470–671 25
ADAMTS13. A database search for the four parkinson’s
diseased targets (UB, PARK2, UBA1, and PINK1) against
the sequences in this cluster resulted in seven hypothetical
sequences from human genome, homologous to the parkin-
sonian target PINK1. The fusions between the domains
cd00192 and cd00180 are conserved in all the hypothetical
sequences and PINK1. Comparison of domain fusions in
hypothetical sequences with their targets is represented in
Table 7. A multiple sequence alignment of these sequences
with PINK1 are shown in Figure 9.
Cluster-8. Cluster-8 has 13 domains spanning 32 hypotheti-
calproteinsequencesasshowninFigure 10.Thefunctionsof
the majority of the domains were related to ubiquitin, PLAT,
and ubiquitin-like domains. Sequences in this cluster were
associated with neurological disorders.
A database search for the four Parkinson’s diseased tar-
gets (UB, PARK2, UBA1, and PINK1) against the sequences
in this cluster resulted into four hypothetical sequences
from human genome, homologous to the parkinsonian
target PINK1. The fusions between the domains cd01488,
cd01489 and cd01490 were observed to be conserved in
all the hypothetical sequences and UBA1. Comparison of
domain fusions in hypothetical sequences with their targets
is represented in Table 8. A pairwise comparison of these
sequences with their targets are shown in Figure 11.
3. Results and Discussions
This study was initiated to understand the diversity of
functions in proteins with multiple-fused domains and to
characterize the hypothetical proteins containing multiple-
fused domains from human genome.
The approach involved characterizing hypothetical pro-
tein sequences (15480) based on identiﬁcation of domains
using the CDD database. This provided 1777 sequences withISRN Neurology 9
cd01330 cd01488
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cd00104
cd01480
cd01202 cd01341 cd01227
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cd01439
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Figure 10: Domains in cluster-8.
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Figure 11: Multiple-sequence alignment of the fused domains in 4 unique hypothetical proteins and their target sequence (UBA1).
domains, of which 984 were single domains and 793 with
multidomain sequences. Of these 793 sequences, 433 were
multidomain-fused proteins. Frequencies of the 433 fused
domain proteins were fed as an input for clustering using
Cytoscape, which yielded a total of 17 clusters, as depicted in
Figure 1.Fourclustersamongstthese17hadubiquitinfused-
domain-containing sequences, which play an important
role in a variety of neuropathological conditions including
Parkinson’s disease, Pick’s disease, and Alzheimer’s disease as
indicated in Table 1. Ubiquitin domain consists of 76 amino
acids and has been found in all eukaryotic cells. Apart from
its use in protein degradation, ubiquitins are also involved in
Parkinson’s disease.
Parkinson’s disease-related genes such as PARK2 and
PINK1 has ubiquitin domains associated with them. Muta-
tions in these sequences have prominently been associated
with the onset of Parkinson’s disease. As a case study,
sequences in Parkinson’s disease were used as basis to
characterize the hypothetical proteins from the above-
mentioned four clusters. From Table 2, it is clear that
ubiquitin/ubiquitin-likedomainsplayadominantroleinthe
onset of Parkinson’s disease. Hence, fused ubiquitin domain
sequences from clusters 1, 2, 5, and 8 were consid-ered
for a detailed investigation to ascertain their roles as well.
Similaritysearchesrevealed18hypotheticalproteins,homol-
ogous with the sequences implicated in Parkinson’s disease,
as shown in Table 3. Sequences in each of these clusters
werethenmultiplyalignedwiththeparkinsoniantargetsUB,
UBA1, PARK2 & PINK1, to ascertain the presence of key
patterns/signatures amongst them. As illustrated in Figures
4,7,9,and11,conservationofresiduesamongsthypothetical
proteins and Parkinson’s sequences is highlighted.
4. Conclusions
We herewith conclude that the presence of fused domain as
a signal in ubiquitin-containing proteins from parkinsonian
targets is used as a probe to identify and characterize the
functions of 18 hypothetical sequences, which could be used
asleaddrugtargetsfordesigningdrugsinParkinson’sdisease
from human genome.
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